We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Laparoscopic Subtotal Hysterectomy Found Effective for Menorrhagia

By HospiMedica staff writers
Posted on 20 May 2008
Laparoscopic subtotal hysterectomy (LSH) is safe and effective treatment for menorrhagia, according to a new study. More...


Researchers of the Princess Royal University Hospital (Orpington, United Kingdom) conducted a prospective observational study and investigated the outcomes (including complication rates and patient acceptability) of 400 consecutive LSHs for menorrhagia resistant to medical treatment (96%), dysfunctional uterine bleeding not responding to hormonal treatment, known symptomatic myomas, or failed previous endometrial ablation. The mean duration of surgery was 46.4 minutes and the mean operative blood loss was 126 ml. Three quarters of the procedures were performed as day cases.

The study results showed that three women (0.75%) sustained bladder entry that was repaired laparoscopically and two (0.5%) incurred bowel injury, and only 7 women (1.7%) developed postoperative infections. There were no postoperative transfusions or returns to the operating theater because of excessive blood loss. Five women ultimately required laparoscopic removal of the cervix because of persistent cyclical vaginal bleeding after the procedure. Women returned to work after an average of two weeks, and most women resumed sexual activity 3 to 4 weeks after surgery; 98% of the women reported satisfaction with the operation and would recommend the procedure to a friend. The study was published in the May 2008 issue of the British Journal of Obstetrics and Gynaecology (BJOG).

"LSH is a safe and effective treatment for menorrhagia and other menstrual disorders when hysterectomy is indicated,” concluded John Erian, M.D., and colleagues of the department of obstetrics and gynecology. "Women appreciate the quick recovery period, reduced time off work and faster return to normal activity. Our data suggest that LSH can replace abdominal hysterectomy in selected cases.”

Menorrhagia (also known as hypermenorrhea) is an abnormally heavy and prolonged menstrual period at regular intervals. Causes may be due to abnormal blood clotting, disruption of normal hormonal regulation of periods, or disorders of the endometrial lining of the uterus. If a normal menstrual cycle is 21-35 days in duration, with bleeding lasting an average of 5 days and total blood flow between 25 and 80 ml, a blood loss of greater than 80 ml or lasting longer than 7 days constitutes menorrhagia. Treatment options include pharmaceutical or surgical and radiological options.


Related Links:
Princess Royal University Hospital

Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Syringes
Prefilled Saline Flush Syringes
Endoscopy Display
E190
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The researchers grew pancreatic tissue (above) so it incorporated a mesh-like electronic network (red). Cells within the tissue produce insulin (green). (Photo courtesy of Penn Medicine)

‘Cyborg’ Transplants Could Replace Pancreatic Tissue Damaged by Diabetes

Type 1 diabetes destroys insulin-producing islet cells, forcing patients to rely on lifelong insulin therapy or scarce organ transplants. Although lab-grown pancreatic tissue offers a promising alternative,... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.